These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 38543856)
1. A Comprehensive Review of Neurodegenerative Manifestations of SARS-CoV-2. Bedran D; Bedran G; Kote S Vaccines (Basel); 2024 Feb; 12(3):. PubMed ID: 38543856 [TBL] [Abstract][Full Text] [Related]
2. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease. Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161 [TBL] [Abstract][Full Text] [Related]
3. COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration? Onaolapo A; Onaolapo O CNS Neurol Disord Drug Targets; 2022; 21(9):818-829. PubMed ID: 34951374 [TBL] [Abstract][Full Text] [Related]
5. Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease? Krey L; Huber MK; Höglinger GU; Wegner F Brain Sci; 2021 Dec; 11(12):. PubMed ID: 34942956 [TBL] [Abstract][Full Text] [Related]
6. Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson's Disease. Awogbindin IO; Ben-Azu B; Olusola BA; Akinluyi ET; Adeniyi PA; Di Paolo T; Tremblay MÈ Front Cell Neurosci; 2021; 15():670298. PubMed ID: 34211370 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses. Smadi M; Kaburis M; Schnapper Y; Reina G; Molero P; Molendijk ML Br J Psychiatry; 2023 Aug; 223(2):348-361. PubMed ID: 37183681 [TBL] [Abstract][Full Text] [Related]
8. Alzheimer's and Parkinson's Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study. Yu Y; Travaglio M; Popovic R; Leal NS; Martins LM Geriatrics (Basel); 2021 Jan; 6(1):. PubMed ID: 33530357 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms highlighting the potential role of COVID-19 in the development of neurodegenerative diseases. Rahmani B; Ghashghayi E; Zendehdel M; Baghbanzadeh A; Khodadadi M Physiol Int; 2022 Jun; 109(2):135-162. PubMed ID: 35895572 [TBL] [Abstract][Full Text] [Related]
11. Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists. Yuen E; Gudis DA; Rowan NR; Nguyen SA; Schlosser RJ Am J Rhinol Allergy; 2021 Jan; 35(1):122-131. PubMed ID: 32762250 [TBL] [Abstract][Full Text] [Related]
12. Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19. Stefano GB; Büttiker P; Weissenberger S; Ptacek R; Wang F; Esch T; Bilfinger TV; Raboch J; Kream RM Curr Neuropharmacol; 2022; 20(6):1229-1240. PubMed ID: 34951387 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 and neurodegenerative diseases. Fu YW; Xu HS; Liu SJ Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4535-4544. PubMed ID: 35776055 [TBL] [Abstract][Full Text] [Related]
14. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice. Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899 [TBL] [Abstract][Full Text] [Related]
15. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535 [TBL] [Abstract][Full Text] [Related]
16. Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson's Disease: A Narrative Review. Morowitz JM; Pogson KB; Roque DA; Church FC Brain Sci; 2022 Apr; 12(5):. PubMed ID: 35624923 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2, COVID-19 and Parkinson's Disease-Many Issues Need to Be Clarified-A Critical Review. Goerttler T; Kwon EH; Fleischer M; Stettner M; Tönges L; Klebe S Brain Sci; 2022 Mar; 12(4):. PubMed ID: 35447986 [TBL] [Abstract][Full Text] [Related]